These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 26390433)
1. Elevated Plasma Soluble ST2 Is Associated with Heart Failure Symptoms and Outcome in Aortic Stenosis. Lancellotti P; Dulgheru R; Magne J; Henri C; Servais L; Bouznad N; Ancion A; Martinez C; Davin L; Le Goff C; Nchimi A; Piérard L; Oury C PLoS One; 2015; 10(9):e0138940. PubMed ID: 26390433 [TBL] [Abstract][Full Text] [Related]
2. Serum levels of the interleukin-1 receptor family member ST2, cardiac structure and function, and long-term mortality in patients with acute dyspnea. Shah RV; Chen-Tournoux AA; Picard MH; van Kimmenade RR; Januzzi JL Circ Heart Fail; 2009 Jul; 2(4):311-9. PubMed ID: 19808354 [TBL] [Abstract][Full Text] [Related]
3. Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction. Pascual-Figal DA; Ordoñez-Llanos J; Tornel PL; Vázquez R; Puig T; Valdés M; Cinca J; de Luna AB; Bayes-Genis A; J Am Coll Cardiol; 2009 Dec; 54(23):2174-9. PubMed ID: 19942089 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of sST2 added to BNP in acute heart failure with preserved or reduced ejection fraction. Friões F; Lourenço P; Laszczynska O; Almeida PB; Guimarães JT; Januzzi JL; Azevedo A; Bettencourt P Clin Res Cardiol; 2015 Jun; 104(6):491-9. PubMed ID: 25586507 [TBL] [Abstract][Full Text] [Related]
6. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Bergler-Klein J; Klaar U; Heger M; Rosenhek R; Mundigler G; Gabriel H; Binder T; Pacher R; Maurer G; Baumgartner H Circulation; 2004 May; 109(19):2302-8. PubMed ID: 15117847 [TBL] [Abstract][Full Text] [Related]
7. Role of Soluble ST2 as a Prognostic Marker in Patients with Acute Heart Failure and Renal Insufficiency. Kim MS; Jeong TD; Han SB; Min WK; Kim JJ J Korean Med Sci; 2015 May; 30(5):569-75. PubMed ID: 25931787 [TBL] [Abstract][Full Text] [Related]
8. Soluble ST2 as a biomarker for detecting stable heart failure with a normal ejection fraction in hypertensive patients. Wang YC; Yu CC; Chiu FC; Tsai CT; Lai LP; Hwang JJ; Lin JL J Card Fail; 2013 Mar; 19(3):163-8. PubMed ID: 23482076 [TBL] [Abstract][Full Text] [Related]
10. Serial soluble ST2 for the monitoring of pharmacologically optimised chronic stable heart failure. Piper SE; Sherwood RA; Amin-Youssef GF; Shah AM; McDonagh TA Int J Cardiol; 2015 Jan; 178():284-91. PubMed ID: 25465308 [TBL] [Abstract][Full Text] [Related]
11. Prognostic value of soluble ST2 in the Valsartan Heart Failure Trial. Anand IS; Rector TS; Kuskowski M; Snider J; Cohn JN Circ Heart Fail; 2014 May; 7(3):418-26. PubMed ID: 24622243 [TBL] [Abstract][Full Text] [Related]
12. Soluble concentrations of the interleukin receptor family member ST2 and β-blocker therapy in chronic heart failure. Gaggin HK; Motiwala S; Bhardwaj A; Parks KA; Januzzi JL Circ Heart Fail; 2013 Nov; 6(6):1206-13. PubMed ID: 24114865 [TBL] [Abstract][Full Text] [Related]
13. Usefulness of plasma B-type natriuretic peptide in the assessment of disease severity and prediction of outcome after aortic valve replacement in patients with severe aortic stenosis. Iwahashi N; Nakatani S; Umemura S; Kimura K; Kitakaze M J Am Soc Echocardiogr; 2011 Sep; 24(9):984-91. PubMed ID: 21570253 [TBL] [Abstract][Full Text] [Related]
14. The prognostic value of plasma soluble ST2 in hospitalized Chinese patients with heart failure. Zhang R; Zhang Y; Zhang J; An T; Huang Y; Guo X; Januzzi JL; Cappola TP; Yin S; Wang Y; Zhou Q; Zou C; Ji S; Lv R PLoS One; 2014; 9(10):e110976. PubMed ID: 25347817 [TBL] [Abstract][Full Text] [Related]
15. Usefulness of an elevated B-type natriuretic peptide in predicting survival in patients with aortic stenosis treated without surgery. Nessmith MG; Fukuta H; Brucks S; Little WC Am J Cardiol; 2005 Nov; 96(10):1445-8. PubMed ID: 16275196 [TBL] [Abstract][Full Text] [Related]
16. ST2 may not be a useful predictor for incident cardiovascular events, heart failure and mortality. Hughes MF; Appelbaum S; Havulinna AS; Jagodzinski A; Zeller T; Kee F; Blankenberg S; Salomaa V; Heart; 2014 Nov; 100(21):1715-21. PubMed ID: 25080471 [TBL] [Abstract][Full Text] [Related]
17. Impact of Serial B-Type Natriuretic Peptide Changes for Predicting Outcome in Asymptomatic Patients With Aortic Stenosis. Henri C; Dulgheru R; Magne J; Caballero L; Laaraibi S; Davin L; Kou S; Voilliot D; Nchimi A; Oury C; Pierard LA; Lancellotti P Can J Cardiol; 2016 Feb; 32(2):183-9. PubMed ID: 26371385 [TBL] [Abstract][Full Text] [Related]
18. Correlation of brain natriuretic peptide levels in patients with severe aortic stenosis undergoing operative valve replacement or percutaneous transcatheter intervention with clinical, echocardiographic, and hemodynamic factors and prognosis. Ben-Dor I; Minha S; Barbash IM; Aly O; Dvir D; Deksissa T; Okubagzi P; Torguson R; Lindsay J; Satler LF; Pichard AD; Waksman R Am J Cardiol; 2013 Aug; 112(4):574-9. PubMed ID: 23683951 [TBL] [Abstract][Full Text] [Related]
19. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Gerber IL; Stewart RA; Legget ME; West TM; French RL; Sutton TM; Yandle TG; French JK; Richards AM; White HD Circulation; 2003 Apr; 107(14):1884-90. PubMed ID: 12668523 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 receptor-related protein ST2 and mitral valve repair outcome in patients with chronic degenerative mitral regurgitation. Galeone A; Lessana A; Mascolo E; Di Serio F; Marraudino N; Laborde F; Paparella D Thorac Cardiovasc Surg; 2014 Feb; 62(1):47-51. PubMed ID: 24065602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]